Know Cancer

or
forgot password

Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer


N/A
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer


Investigators will first ask patients to answer a series of questions to assess their wishes
regarding treatment, knowledge about their disease and discussion with the physicians at
initial patient visit. This initial survey should take approximately 20 minutes. Once
patients have selected a treatment path investigators will contact them again and ask them
to fill out a short 10-minute survey online or by mail. Investigators will contact patients
by phone 2 weeks after their initial visit to see if they have made a decision. If not,
investigators will contact patients by phone every 2 weeks or at an interval that works for
the patient's schedule. Finally, 3 months after the initial visit today investigators will
contact patients for the last time and again ask you to fill out a short 10-minute survey
online or by mail.

Once patients have completed the final survey there are no future surveys planned.
Investigators may contact patients by phone in the future to ask them to participate in
another study.


Inclusion Criteria:



- Histologically confirmed prostate adenocarcinoma

- Internet access

- Able to read and understand English

Exclusion Criteria:

- Evidence of nodal metastases

- Evidence of distant metastases

- Prior surgery, chemotherapy, pelvic radiation or prostate brachytherapy for prostate
cancer

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Patient knowledge regarding the available treatment options for low-risk prostate cancer and their potential side effects.

Outcome Description:

Investigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Jason A. Efstathiou, MD, DPhil

Investigator Role:

Principal Investigator

Investigator Affiliation:

Massachusetts General Hospital

Authority:

United States: Institutional Review Board

Study ID:

11-463

NCT ID:

NCT01673581

Start Date:

August 2012

Completion Date:

Related Keywords:

  • Prostate Cancer
  • Low Risk
  • Prostatic Neoplasms

Name

Location

Massachusetts General HospitalBoston, Massachusetts  02114-2617